Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ.
R CurminS GuilloY De RyckeH BachelezMarie Beylot-BarryN BenetonOlivier ChosidowA DupuyPascal JolyDenis JullienMarie Aleth RichardM ViguierEmilie SbidianC PaulEmmanuel MahéF Tubachnull nullPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
This study described the switching patterns of biologic treatments and showed how they changed over time, due to the availability of the new biologic agents primarily IL-17 inhibitors.